Japan Syringe Market Size, Share, Opportunities, And Trends By Type (Insulin Syringe, Conventional Syringe), By Material (Glass, Plastic, Stainless Steel), And By Syringe Size (Smaller Volume Syringe, Larger Volume Syringe) - Forecasts From 2023 To 2028

A syringe is a cylindrical medical tool used to inject/withdraw a solution into/from a human body. The syringe market is a key element of the pharmaceutical industry. Due to the spread of infections and diseases using reusable syringes made from stainless steel, disposable syringes witnessed a rise in demand. Due to the sterilization and safety protection offered by disposable syringes, the Japan Syringe market has witnessed an increase in demand for new syringes and needles to adhere to the safety measures and precautions established by the National Medical Board. The increasing population and developments in the healthcare industry have opened up opportunities for better sales and expansion of the Japanese syringe market.

The increasing need for vaccines and medicines acts as a market driver promoting the expansion of Japan’s syringe market.

The increasing need for vaccines and medicines due to the emergence of new diseases and epidemics/pandemics is a leading factor behind the upward trend of the Japan Syringe market. For instance, the recent situation of COVID-19 led to a dramatic increase in the demand for vaccines designed to fight against the Corona Virus. Therefore, with the increase in the need for vaccines and medicines to be injected into the patients, the need to produce syringes increases. Further, after the initial dose of the vaccinations, the demand for syringes remained high for booster doses. Other than emergency needs during an epidemic or a pandemic, syringes remain in high demand owing to their most common use as medical tools. According to the Japanese Government, cancer deaths increased to 0.4 million people. This shows that the number of cancer patients in Japan is on the rise, leading to more demand for cancer medications. In addition to this, there are a number of vaccinations given to infants and injections offered to patients to target the diseases they are fighting against. Therefore, due to its extensive use in providing medicines to patients, the Japan Syringe market shall continue to expand gradually.

The use of syringes as a blood-extracting and anaesthesia-injecting tool further promotes the growth of Japan syringe market.

The increasing population indicates the need for an increase in medical care facilities and attention, creating more demand for medicines and medical tools like syringes. In addition to this, one of the common methods used to administer anaesthesia is the use of syringes. For caesarean operations, local anaesthesia is injected by using needles attached to syringes and according to the Japanese Government, the number of pregnant women opting for caesarean has been increasing steadily since the start of this decade. This shows that the demand for syringes is likely to rise gradually henceforth. This shows that the demand for syringes is likely to rise gradually henceforth. Therefore, all these factors contribute to the steady growth of the Japan’s syringe market.

However, the emergence of alternatives to syringes like insulin pens and needle-free injectors could be a restraining factor for the growth of Japan’s syringe market. The Japanese syringe market is facing strong competition from new technological innovations like Insulin pens that are used to inject insulin into a diabetic patient without the use of a syringe. Other than insulin pens, biotechnological companies continuously strive to innovate new products, leading to creations like needle-free injectors that can be used without syringes. However, due to the sceptical perception of these new technological innovations since the products are relatively new to the market, the Japan syringe market can be expected to experience steady expansion over the next few years.

Key Developments

• In August 2021, Otsuka Pharmaceuticals, a Japanese company announced the launch of a new syringe injection named Ajovy as a medication for migraine, as a result of its license agreement with Teva Pharmaceutical Industries Ltd.
• In September 2020, BD Company announced that it will be investing $1.2 billion in its six manufacturing units to increase its production capacity of pre-fillable syringes. One of these manufacturing units is located in Japan.  

Japan Syringe Market Scope:

Key Market Segments:

• By Type
  • Insulin Syringe
  • Conventional Syringe
    • Eccentric Tip Syringe
    • Catheter Tip Syringe
    • Luer Lock Syringe
• By Material
  • Glass
  • Plastic
  • Stainless Steel
• By Syringe Size
  • Smaller Volume Syringe
  • Larger Volume Syringe